VRAX   $0.174  -10.31% Market Closed After Close 0.1649 -5.23%

Virax Biolabs Group Limited
Total Cash 3.67M
totalCashPerShare 1.425
EBITDA -6.05M
Total Debt 224.30K
quickRatio 23.005
currentRatio 25.942
Total Revenue 156.42K
debtToEquity 4.365
Revenue/Share 0.078
ROA -0.49898
ROE -0.9598
grossProfits
freeCashflow -4.99M
operatingCashflow -6.25M
earningsGrowth
revenueGrowth 27.522
grossMargins 0.32342997
ebitdaMargins 0.0
operatingMargins -42.54122
profitMargins 0.0
enterpriseValue 1.22M
forwardPE
floatShares 2.40M
sharesOutstanding 4.34M
sharesShort 231.83K
sharesShortPriorMonth 175.57K
dateShortInterest
sharesPercentSharesOut 0.05%
heldPercentInsiders 0.07%
heldPercentInstitutions 0.02%
Short Ratio help_outline 0.21%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 2.085
Price To Book help_outline 0.91
earningsQuarterlyGrowth
netIncomeToCommon -6.73M
trailingEps -3.36%
forwardEps -1.90%
enterpriseToEbitda -0.20
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 8
lastUpdated Nov. 7, 2024, 3:02 p.m.